PT - JOURNAL ARTICLE AU - Vestesson, Emma AU - Alonso, Carlos AU - Booth, John AU - Sebire, Neil J AU - Steventon, Adam AU - Tomlin, Steve AU - Standing, Joseph F TI - Changes in hospital prescribing activity at a specialist children’s hospital during the COVID-19 pandemic - an observational study AID - 10.1101/2020.12.21.20248153 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.21.20248153 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248153.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248153.full AB - Objective To compare hospital activity, patient casemix and medication prescribing and administration before and during the COVID-19 emergency.Design Retrospective observational studySetting A specialist children’s hospital in the UKPatients Inpatients aged 25 and younger treated at a specialist children’s hospital between 29 April 2019 and 6 September 2020Results There were 21,471 day cases and inpatients treated during the 16 month study period. Day cases (no overnight stay) dropped by around 37% per week. Both admissions and discharges for inpatients (at least one overnight stay) decreased leading to a small reduction in hospital bed days but no reduction in hospital bed nights. The effect on hospital activity on different patient groups varied substantially with some groups such as medical oncology day cases increasing by 13%. As a result, the patient case mix in the hospital was very different during the pandemic. Overall weekly medication administrations decreased for day cases and inpatients, but weekly medication administrations per bed day increased by 10% for day cases and 6% for inpatients.Conclusions Despite not being badly affected by the disease itself, specialist paediatric hospital services have been greatly affected by the pandemic. The average number of medications per inpatient bed day increased, likely reflecting changes to the patient population, with only those children with severe conditions being treated during the pandemic. These data demonstrate the complex pattern of implications on specialist services and provide evidence for planning the impact of future emergencies and resolution strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Health Foundation supports E.V's PhDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:London - South East Research Ethics Committee - REC approval 17/LO/0008 (Favourable opinion)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be obtained from a third party and are not publicly available.